Invention Grant
- Patent Title: Selective inhibition of gluconeogenic activity
-
Application No.: US16496178Application Date: 2018-03-21
-
Publication No.: US11247970B2Publication Date: 2022-02-15
- Inventor: Pere Puigserver , Kfir Sharabi , Theodore Kamenecka , Patrick Griffin , Stuart L. Schreiber , Roger Schilling , Partha P. Nag , Joshua A. Bittker
- Applicant: Dana-Farber Cancer Institute, Inc. , The Scripps Research Institute , The Broad Institute, Inc.
- Applicant Address: US MA Boston; US CA La Jolla; US MA Cambridge
- Assignee: Dana-Farber Cancer Institute, Inc.,The Scripps Research Institute,The Broad Institute, Inc.
- Current Assignee: Dana-Farber Cancer Institute, Inc.,The Scripps Research Institute,The Broad Institute, Inc.
- Current Assignee Address: US MA Boston; US CA La Jolla; US MA Cambridge
- Agency: Foley Hoag LLP
- Agent DeAnn F. Smith; Janine S. Ladislaw
- International Application: PCT/US2018/023497 WO 20180321
- International Announcement: WO2018/175537 WO 20180927
- Main IPC: C07D209/08
- IPC: C07D209/08 ; C07D223/28 ; A61P3/10 ; C07D207/09 ; C07D333/34 ; C07D401/04 ; C07D401/12 ; C07D405/12 ; C07D495/04 ; C07D498/04 ; A61K45/06
Abstract:
The present invention provides compounds, pharmaceutical compositions and methods for treating and/or preventing a metabolic condition, such as diabetes.
Public/Granted literature
- US20200317620A1 SELECTIVE INHIBITION OF GLUCONEOGENIC ACTIVITY Public/Granted day:2020-10-08
Information query
